secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensei Biotherapeutics, Inc. (SNSE)
CIK:        0001829802
Form:       8-K
Filed at:   2024-06-13T23:59:59+00:00
Accession:  0001193125-24-160769
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Sensei Biotherapeutics stockholders reelect all three director nominees at 2024 annual meeting
--------------------------------------------------------------------------------

- Elected directors Jessie English, James Peyer, Thomas Ricks; each received ~9-10M votes for, ~0.8-1.9M withheld.
- Ratified Deloitte & Touche as independent auditor for FY 2024 with 16.3M for, 0.8M against, 17k abstentions.
- Approximately 68.2% of outstanding shares (17.1M of 25.1M) were present or represented at the meeting.
- Broker non-votes on director election totaled ~6.1M for each nominee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829802/000119312524160769/0001193125-24-160769-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829802/000119312524160769/d806149d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-160769

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer